Antiretroviral drug: Treatment and care of HIV victims according to studies.
- This is the main type of treatment for HIV or AIDS. It is not a cure, but it can stop people from becoming ill for many years.
Antiretroviral drugs, an attempt to control HIV infection in the body or for treatment and care of HIV victims. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle.
The use of multiple drugs that act on different viral targets is known as highly active antiretroviral therapy (HAART). HAART decreases the patient’s total burden of HIV, maintains function of the immune system, and prevents opportunistic infections that often lead to death.
The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive.
Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.HIV treatment has been proven so successful that in many parts of the world HIV has become a chronic condition in which progression to AIDS has become increasingly rare.
On Sunday, Dr. Meg Doherty of the WHO Department of HIV / AIDS told a satellite meeting ahead of the Eight International AIDS Society Conference in Vancouver that World Health Organization will issue new HIV treatment guidelines later this year recommending treatment for all, regardless of CD4 cell count.
The treatment and care of HIV victims– HIV victims should be given directly for this people can live long and healthy lives with access to treatment and care.
Since HIV was first reported substantial progress in the research and development of antiretroviral drugs has been made. There are now more than 20 approved antiretroviral drugs. Despite this, people with HIV face many barriers to accessing affordable, effective HIV treatment.
According to Charles Lyons, EGPAF president and CEO. “It is vital that children are not lost in the crowd, when children are considered only as part of the greater HIV population, they inevitably get left behind.
Time and time again we’ve seen that failing to focus on children living with HIV has left the majority of them without the care and treatment they desperately need.
Children living with HIV require unique, intensive actions to identify them and ensure they have access to and remain on treatment.
We must acknowledge these differences and incorporate the specific needs of children in global guidelines and targets.
Otherwise, we may end up moving backward when we desperately need forward momentum to drive us toward an AIDS-free generation.